AIKIDO PHARMA INC

Versiunea din 18 septembrie 2024 15:36, autor: Admin (discuție | contribuții) (Pagină nouă: Pagina dedicata companiei AIKIDO PHARMA INC listata cu simbolurile US.AIKI, US.AIKIc ==Descriere companie== AIkido Pharma Inc.(https://aikidopharma.com/), a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. Its pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute mye...)
(dif) ← Versiunea anterioară | Versiunea curentă (dif) | Versiunea următoare → (dif)

Pagina dedicata companiei AIKIDO PHARMA INC listata cu simbolurile US.AIKI, US.AIKIc

Descriere companie

AIkido Pharma Inc.(https://aikidopharma.com/), a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. Its pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The Company is also developing an antiviral platform that inhibits replication of multiple viruses, including influenza virus, SARS-CoV, MERS-CoV, Ebolavirus, and Marburg virus. It has a license agreement with the University of Texas; and Wake Forest University Health Sciences. The company was formerly known as Spherix Incorporated and changed its name to AIkido Pharma Inc. in March 2021. AIkido Pharma Inc. was founded in 1967 and is based in New York, New York.

Grafic actiuni companie

Ultimele stiri despre AIKIDO PHARMA INC (US.AIKI)

Ultimele stiri despre AIKIDO PHARMA INC (US.AIKIc)